Conversely, low levels of sclerostin or SOST gene mutations can implicate several genetic skeletal disorders with high bone mineral density (BMD), such as sclerosteosis and van Buchem disease [1,2,6]. Here, SOST is linked to hyperostosis corticalis generalisata.